Purpose Leptin, an adipose secreted cytokine, is implicated in mammary cancer stem cell self-renewal and tumor growth in murine mammary tumor virus (MMTV)-Wnt-1 transgenic mice. In vitro studies indicate that leptin induces expression of cyclin D1, a cell-cycle control protein necessary for mammary tumor development. The aim of the present study was to assess cyclin D1 expression in spontaneous tumors that develop in the MMTV-Wnt-1 transgenic mice and interrogate the in vivo effect of leptin. Materials and methods Cells derived from spontaneous MMTV-Wnt-1 tumors were orthotopically transplanted into wild-type, leptin-deficient, and hyperleptinemic mice. After 6 weeks, tumors were collected and formalin fixed. Immunoflurescence staining was used to assess cyclin D1, keratin 8, a-SMA, phospho-AKT expression. Results Cyclin D1 is expressed exclusively in luminal keratin 8 immunoreactive tumor cells and is dependent on the adipose secreted hormone leptin. Tumor cell transplant into leptin-deficient mice resulted in approximately an 80 % reduction of cyclin D1 immunoreactivity in keratin 8 luminal epithelial cells, and this was independent of Akt activation.
Introduction
Obesity is an established risk factor for breast cancer in postmenopausal women (Di Carlo et al. 2004; Phipps et al. 2008) . The molecular mechanisms underlying the relationship between obesity and breast cancer are not fully understood. Leptin is a product of human obese (ob) gene (Zhang et al. 1994) , synthesized in adipose tissue, and elevated in obese individuals (Halberg et al. 2008; Fruhbeck et al. 2001) . Its predominant function is in regulation of feeding behavior, metabolism, and body weight by binding to the leptin receptor (LEPR) in the brain (Friedman 1998) . However, leptin and its receptors are also highly expressed in multiple peripheral tissues and tumors (Park and Scherer 2011) . In fact, nearly 90 % of primary breast tumors express leptin and its expression is highly correlated with LEPR (Garofalo et al. 2006) . Moreover, Leptin and LEPR are increased in Bloom-Richardson grade III carcinomas compared to grade I carcinomas in human breast cancers. Leptin and LEPR expression are associated with shorter time to tumor recurrence and patient death (Ishikawa et al. 2004; Garofalo et al. 2006; Miyoshi et al. 2006; Maccio et al. 2010) . The mechanisms of peripheral leptin signaling in breast cancer progression remain incompletely understood. Leptin elevates estrogen levels via increased aromatization of androgens (Cirillo et al. 2008) , and leptin also transactivates HER2/neu (Fiorio et al. 2008) . In addition to its crosstalk with estrogen and other signaling pathways in breast cancers, leptin has been shown to directly increase tumor cell survival and proliferation in vitro through LEPR (Hu et al. 2002) .
Murine mammary tumor virus (MMTV) Wnt-1 transgenic mice develop spontaneous mammary tumors that exhibit characteristics of human basal-like breast cancers. Importantly, MMTV-Wnt-1 tumors develop in a hierarchical manner from a stem cell-like cancer cell (also known as a cancer stem cell, CSC) that can give rise to multiple lineages and tumor cell populations. Using fluorescence-activated cell sorting and immunohistology, the multiple cell populations have been identified and isolated including putative CSCs, myoepithelial and luminal progenitors, and mature differentiated cancer cells such as luminal and myoepithelial cells (Cho et al. 2008; Jeselsohn et al. 2010) . Our published findings indicated that leptin deficiency leads to decreased levels of Akt phosphorylation and reduced Wnt-1 tumor growth (Zheng et al. 2011) . Moreover, leptin deficiency significantly decreased a subpopulation of cells within Wnt-1 tumors that exhibit CSC behavior, which leads to reduction in tumorigenesis (Zheng et al. 2011) .
The cell-cycle regulator cyclin D1 is required for mammary progenitor cell self-renewal and luminal epithelial cell differentiation (Cho et al. 2008; Jeselsohn et al. 2010) . Cyclin D1 promotes the progression of the cell cycle by activating cyclin D-dependent kinase 4/6, which leads to phosphorylation of the retinoblastoma protein and in turn to progression through the G1 phase of the cell cycle. In vitro studies show that leptin induces cyclin D1 through Janus Kinase 2 (JAK2) with subsequent activation of several signaling pathways including phosphatidylinositol 3-kinase (PI3K)/Akt and the signal transducer and activator of transcription-3 (STAT3) (Gonzalez et al. 2006; Saxena et al. 2004 Saxena et al. , 2007 Chen et al. 2007; Yan et al. 2012) . Therefore, we hypothesized that leptin deficiency would decrease cyclin D1 expression in cancer cells and lead to loss of tumor cells. To test this hypothesis, we assessed cyclin D1 expression in MMTVWnt-1 tumors and investigated the effect of leptin.
Materials and methods

Antibodies
The keratin 8 antibody (throma1) was obtained from the Developmental Studies Hybridoma Bank the University of Iowa, Department of Biology, Iowa City, IA. Keratin 6 was purchased from Covance (Princeton, NJ), a-SMA was purchased from Sigma (St. Louis, MO), and cyclin D1 and p-AKT were purchased from Cell Signaling (Danvers, MA). All secondary antibodies including Alexa fluor 488 and 568 goat anti-rabbit, goat anti-rat were purchased from Molecular Probes (Eugene, OR).
Mice
Wild-type C57BL/6J (WT), leptin-deficient (B6. V-Lep ob /J; ob/ob), and leptin receptor-deficient (B6. BKS (D)-Lepr db /J; db/db) mice were purchased from the Jackson Laboratory. The MMTV-Wnt-1 mice were kindly provided by Dr. Stephen Hursting. All mice were maintained in microisolator units and provided free access to food and water. All mouse procedures were performed under strict adherence to protocols approved by the Institute Animal Care and Use Committee at the Lerner Research Institute, Cleveland Clinic Foundation.
Transplantation of Wnt-1 mammary tumor cells MMTV-Wnt-1 mammary tumors were minced with a scalpel and dissociated for 1 h at 37°C on a rotary shaker in Medium 199 (invitrogen, Grand Island, NY, USA) supplemented with 0.28 WUnsch units/ml liberase TH and TM (Roche, Indianapolis, IN, USA) and 100Kunitz units/ml DNase I (SigmaAldrich St. Louis, MO, USA). Sample were pipetted every 20 min while shaking. Cells were passed through 40-lm filter and centrifuged at 1,000 rpm for 5 min. Cells were orthotopically transplanted (50,000 cells/mouse) into the right mammary fat pad #4 of female mice at 6 weeks of age (n = 6-10). Mice were euthanized after 6 weeks, and the tumors were collected for immunofluorescence.
Immunofluorescence analysis
Sections were deparaffinized by Histoclear (National Diagnostics, Atlanta, GA, USA) and rehydrated in graded alcohols. After antigen retrieval, sections were blocked with 2 % goat serum in PBS for 1 h at room temperature and then incubated overnight with antibody to keratin 8, 6, a-SMA, cyclin D1, and p-AKT. The next day, sections were washed and incubated for 1 h with fluorescent secondary antibody at room temperature. Images were acquired using an epifluorescent digital microscope (Leica Microsystems, Buffalo Grove, IL, USA).
Results
Cyclin D1 is expressed in keratin 8
? luminal epithelial cells of mouse MMTV-Wnt-1 mammary tumors
We previously used lineage selective markers and analyzed cell types of mouse MMTV-Wnt-1 tumors by immunofluorescence (IF) (Zheng et al. 2011 ) (Zheng et al. 2011) . In this study, we first assessed cyclin D1 localization by IF staining and found that approximately 10 % of cells expressed nuclear cyclin D1 in MMTV-Wnt-1 tumors transplanted into WT mice (Fig. 1a, j) . Moreover, we observed that cyclin D1 was expressed almost exclusively in K8
? luminal epithelial cells (Fig. 1b, c) .
Leptin regulates the expression of cyclin D1
In order to investigate the role of leptin on cyclin D1 expression, we transplanted spontaneous Wnt-1 tumors into leptin-deficient ob/ob and hyperleptinemic db/db mice. The tumors that developed were formalin fixed, and cyclin D1 expression was detected by immunofluorescence. Cyclin D1 was observed in less than 2 % of cells in ob/ob mice, an 80 % reduction compared to WT mice (Fig. 1d, j) . In contrast, in db/db mice with high circulating leptin, cyclin D1 was expressed in greater than 20 % of the tumor cells, or two fold higher compared to WT mice (Fig. 1g, j) . Additionally, the loss of cyclin D1 in ob/ob mice did not noticeably alter histopathologic features of luminal epithelial cells or the expression of K8 (Fig. 1e, f) .
Cyclin D1 expression is rescued by serial transplantation of Wnt-1 tumor cells from ob/ob mice into wild-type mice
We next transplanted tumor cells from residual tumors derived from WT or ob/ob mice into recipient WT mice. The serial transplantation of Wnt-1 tumor cells from ob/ob mice into the WT mice led to reexpression of cyclin D1 (Fig. 2) . This suggests that cyclin D1 expression in MMTV-Wnt-1 mammary tumors is leptin dependent and provides in vivo evidence for the cell studies indicating that leptin induces cyclin D1 expression.
Leptin regulates cyclin D1 in an AKT-independent manner
Leptin induces cyclin D1 through JAK2 kinase and subsequent activation of several signaling pathways including Akt and STAT3 signaling. Because we previously reported that leptin activates Akt in MMTV-Wnt-1 tumors (Zheng et al. 2011) , we assessed whether cyclin D1 is co-localized to the p-Akt overexpressing mammary cancer cells. Wnt-1 tumors were co-stained with p-Akt and K8 or with a-SMA (myoepithelial lineage marker). Akt phosphorylation did not colocalize with either K8 ? (Fig. 3a) or a-SMA ? cells (Fig. 3b) . Comparison of adjacent sections indicates that (2012) 138:1607-1612 1609 activated Akt is within the region in which K6 is coexpressed (Fig. 3c) . The data suggest that leptin-induced cyclin D1 expression is independent of Akt activation.
Discussion
We report here that cyclin D1 is expressed exclusively in luminal K8 expressing mammary tumor cells and that cyclin D1 expression in MMTV-Wnt-1 tumors is dependent on leptin. These data suggest a role of leptin in cyclin D1 expression in vivo. The current data combined with our previous study (Zheng et al. 2011) show that therapeutics to inhibit leptin signaling may block multiple oncogenic pathways implicated in breast tumorigenesis. Cyclin D1 is highly expressed in both mouse mammary tumors and human primary breast carcinomas (Kenny et al. 1999; Gillett et al. 1994) . We observed that the normal mouse mammary tissue did not show strong nuclear cyclin D1 expression (data not shown), while cyclin D1 is highly expressed in mouse MMTV-Wnt-1 mammary tumors. The MMTV-Wnt-1 mammary tumors include multiple subtypes of cells including luminal (K8 ? ), myoepithelial (aSMA) and basal progenitor cells (K6 ? ). In this study, we provide direct evidence for cyclin D1 expression in luminal epithelial cells. This is in agreement with a recent study that showed cyclin D1 is required for luminal cell differentiation in the mammary gland (Jeselsohn et al. 2010) . Further, cyclin D1 homozygous null mice are resistant to initiation of luminal mammary tumors induced by the neu and ras oncogenes, whereas the mice remain sensitive to MMTVWnt-1-induced tumorigenesis (Jeselsohn et al. 2010; Yu et al. 2001) . Collectively, these data indicate that cyclin D1 marks the luminal progenitor population in mammary carcinomas and thus targeting signaling pathways that activate cyclin D1 may be an attractive therapeutic approach to inhibit luminal type mammary tumors.
Our findings indicate that leptin signaling is necessary for expression of cyclin D1 in the luminal progenitor population of MMTV-Wnt-1 mice. Leptin receptor is expressed in estrogen receptor positive breast cancer cells and luminal type tumors (Kim 2009; Ishikawa et al. 2004 ). This has significant ramifications and suggests that inhibiting leptin signaling would yield effective therapeutic approaches for targeting luminal mammary tumors. Indeed, the near complete inhibition in cyclin D1 expression in the transplanted MMTV-Wnt-1 tumors in leptin-deficient mice supports this hypothesis.
Leptin induces cyclin D1 through several JAK2-dependent signaling pathways. Leptin via JAK2 activates Akt to phosphorylate GSK 3b that leads to increased accumulation of b-catenin and cyclin D1 expression in the nucleus (Alt et al. 2000) . In addition, leptin activates STAT3 and directly stimulates cyclin D1 activation. We recently published that activated Akt (phosphorylated Akt) is expressed in a leptin-dependent manner in MMTV-Wnt-1 tumors Fig. 2 Rescue of cyclin D1 expression in tumor cells injected into wild-type mice. Cells arose from MMTV-Wnt-1 tumors that developed in WT or ob/ob mice were transplanted into WT mice. The transplantation of ob/ob tumors cells into the wild-type host rescue the cyclin D1 (green) expression. Nuclei were counterstained with DAPI (dark blue). Scale bar 100 lm (Zheng et al. 2011) . Our current studies show that in MMTV-Wnt-1 tumors, leptin activates cyclin D1 independent of Akt. Notably, comparison of adjacent sections indicates that p-Akt is colocalized in K6
? cells that are associated with CSCs (Li et al. 2003; Stingl et al. 2006 ). These findings suggest that activation of Akt by leptin may play an important role in maintaining undifferentiated cancer stem/progenitor cells.
The current data combined with our previous study (Zheng et al. 2011) indicate that inhibition of leptin signaling provides an excellent therapeutic target for breast cancer. Leptin can stimulate Akt in undifferentiated cancer stem/progenitor cells and in parallel regulate cyclin D1 expression in the luminal progenitor tumor cells. We propose that leptin therapeutics may inhibit breast cancer by more then one mechanism. In luminal mammary tumors, leptin antagonists would potentially inhibit growth via a cyclin D1-dependent mechanism. In basal mammary cancer, leptin antagonists would inhibit growth via an Aktdependent manner leading to reduced CSC self-renewal. c Immunofluoresence analysis of keratin 6 (green, left) and p-AKT (green, right) in adjacent MMTV-Wnt-1 tumor sections. Nuclei were counterstained with DAPI (dark blue). Scale bar 100 lm Conflict of interest None.
